pH-dependent regulation of leukocyte 5-lipoxygenase activity in inflammatory exudates by albumin

Inflammation Research

Volumn 46, Issue 9, 1997, Pages 366-372

  Benz, M ^a,b   Werz, O ^a   Jacob, R ^b   Steinhilber, D ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

In vivo animal models; Inflammation; Inflammatory mediators; Lipid mediators; Neutrophils

Indexed keywords

ALBUMIN; ARACHIDONATE 5 LIPOXYGENASE; CALCIMYCIN; CELL ENZYME; ENZYME INHIBITOR; GLYCOGEN; LEUKOTRIENE; PERITONEAL DIALYSIS FLUID; THIOL GROUP;

ALKALINITY; ANIMAL CELL; ARTICLE; CELL STIMULATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; EXTRAVASATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; LEUKOCYTE; MALE; NONHUMAN; PERITONEUM LAVAGE; PH; PROTEIN CONFORMATION; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ASCITIC FLUID; CATTLE; ENZYME INHIBITORS; GLYCOGEN; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTES; MALE; PEPTIDE FRAGMENTS; PERITONEAL LAVAGE; PERITONITIS; RATS; RATS, WISTAR; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE;

EID: 0030800316     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050203     Document Type: Article

References (33)

1. Samuelsson B, Dahlén S-E, Lindgren J-Å, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987;237:1171-6.
2. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway - biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323:645-55.
3. Clancy RM, Dahinden CA, Hugli TE. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-met-leu-phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci USA 1983;80: 7200-4.
4. Sellmayer A, Strasser T, Weber PC. Differences in arachidonic acid release, metabolism and leukotriene B4 synthesis in human polymorphonuclear leukocytes activated by different stimuli. Biochem Biophys Acta 1987;927:417-22.
5. Rouzer CA, Kargman S. Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 1988;263:10980-8.
6. Woods JW, Evans JF, Ethier D, Scott S, Vickers PJ, Hearn L, et al. 5-Lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 1994; 178:1935-46.
7. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, et al. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 1990;343:282-4.
8. Mancini JA, Abramovitz M, Cox ME, Wong E, Charleson S, Perrier H, et al. 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett 1993;318:277-81.
9. Dahlén SE, Hansson G, Hedqvist P, Björck T, Granström E, Dahlén B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4 and E4. Proc Natl Acad Sci USA 1983; 80:1712-6.
10. Klickstein LB, Shapleigh C, Goetzl EJ. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 1980;66:1166-70.
11. Bos OJM, Fischer MJE, Wilting J, Janssen LHM. Procedure for the isolation of a large peptic fragment of human serum albumin. J Chromatogr 1988;424:13-21.
12. Bos OJM, Fischer MJE, Willing J, Janssen EHM. Drug-binding and other physicochemical properties of a large peptic fragment of human serum albumin. Biochim Biophys Acta 1988;953:37-47.
13. Bos OJM, Remijn JPM, Fischer MJE, Wilting J, Janssen LHM. Location and characterization of the warfarin binding site of human serum albumin. Biochem Pharmacol 1988;37:3905-9.
14. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
15. Steinhilber D, Herrmann T, Roth HJ. Separation of lipoxins and leukotrienes from human granulocytes by high-performance liquid chromatography with a Radial-Pak cartridge after extraction with an octadecyl reversed-phase column. J Chromatogr 1989;493: 361-6.
16. Pirisino R, DiSimplicio P, Ignesti G, Bianchi G, Barbera P. Sulfhydryl groups and peroxidase-like activity of albumin as scavenger of organic peroxides. Pharmacol Res Commun 1988; 20:545-52.
17. Hatzelmann A, Schatz M, Ullrich V. Involvement of glutathione peroxidase activity in the stimulation of 5-lipoxygenase activity by glutathione-depleting agents in human polymorphonuclear leukocytes. Eur J Biochem 1989;180:527-33.
18. Pember SO, Barnes KC, Brandt SJ, Kinkade JM. Density heterogeneity of neutrophilic polymorphonuclear leukocytes: Gradient fractionation and relationship to chemotactic stimulation. Blood 1983;61: 1105-15.
19. Chen XS, Sheller JR, Johnson EN, Funk CD. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994;372:179-82.
20. Leonard WJJ, Vijai KK, Foster JF. A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotatory dispersion studies. J Biol Chem 1963;238: 1984-8.
21. Bos OJM, Labro JFA, Fischer MJH, Wilting J, Janssen LHM. The molecular mechanism of the neutral-to-base transition of human serum albumin. J Biol Chem 1989;264:953-9.
22. Era S, Itoh KB, Sogami M, Kuwata K, Iwama T, Yamada H, et al. Structural transition of bovine plasma albumin in the alkaline region - the N-B transition. Int J Pept Protein Res 1990;35:1-11.
23. 4. J Biol Chem 1982;257:4680-3.
24. 4 from human polymorphonuclear leukocytes. J Biol Chem 1996;271:17944-8.
25. Abramovitz M, Wong E, Cox ME, Richardson CD, Li C, Vickers PJ. 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem 1993;215:105-11.
26. Krump E, Borgeat P. Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: Effects of granulocyte-nuicrophage colony-stimulating factor. Biochim Biophys Acta 1994;1213:135-9.
27. Reed RG, Burrington CM. The albumin receptor effect may be due to a surface-induced conformational change in albumin. J Biol Chem 1989;264:9867-72.
28. Schnitzer JE, Carley WW, Palade Ge. Albumin interacts specifically with a 60-kDa microvascular enthothelial glycoprotein. Proc Natl Acad Sci USA 1988;85:6773-7.
29. Colli S, Marinovich M, Stragliotto E, Galli CL, Tremoli E. Inhibition of human neutrophil aggregation by albumin. Biochem Pharmacol 1989;38:3909-12.
30. Nathan C, Xie QW, Halbwachs-Mecarelli L, Jin WW. Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J Cell Biol 1993;122:243-56.
31. Ursini F, Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 1987;44:255-76.
32. Janatova J, Fuller JK, Hunter MJ. The heterogeneity of bovine albumin with respect to sulfhydryl and dimer content. J Biol Chem 1968;243:3612-22.
33. Edlow DW, Sheldon WH. The pH of inflammatory exudates. Proc Soc Exp Biol Med 1971;137:1328-32.